The EU is part of a pharmaceutical arrangement with the US, Japan, Canada, Switzerland, Norway and Macao, which provides duty-free treatment to pharmaceutical products and to their ingredients from its members. The list of products covered is to be reviewed. Companies wanting to propose products for the review are invited to contact DG TRADE by 15 September. Read more...